Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
American Bio Medica Stock Quote

American Bio Medica (OTC: ABMC)

$0.00
(0.0%)
$0.00
Price as of April 25, 2024, 10:29 a.m. ET

American Bio Medica Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ABMC -97.38% -99.57% -66.33% -100%
S&P +23.33% +73.48% +11.63% +1,518%

American Bio Medica Company Info

American Bio Medica Corp. is a biotechnology company, which engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The firm's products include Rapid Drug Screen, Rapid ONE, RDS InCup, Rapid TOX, Rapid TOX Cup II, and OralStat. Its products are related to urinalysis, oral fluids, alcohol testing, hair testing, pregnancy testing, and lab partners. The company was founded by Stan Cipkowski and Edmund M. Jaskiewicz on April 2, 1986 and is headquartered in Kinderhook, NY.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.